• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 15, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Symposium turns spotlight on brain research

Bioengineer by Bioengineer
January 6, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

RIVERSIDE, Calif. – The brain is home to two kinds of cells: neurons and glia, with the latter protecting the former. Glia, the stuff between neurons, are important also because they regulate and define neuron-neuron communication.

The study of glia is so intense that an annual symposium held at the University of California, Riverside on how glial-neuronal interactions impact health and disease is in its 10th year.

The next "Glial-neuronal Interactions in Health and Disease" symposium will take place on Friday, Jan. 13, 2017, and is expected to attract about 230 top brain-researchers. Scientists attending the symposium will discuss and present their latest findings in glial-neuronal interactions – now one of the most active pursuits in brain research.

The symposium is from 9:30 a.m. to 6 p.m. in Room 302 of the Highlander Union Building, a short walk from the bell tower on campus. Registration is free for attendees from UC Riverside, non-profit organizations and the media. For others, registration costs $175 per person, which includes lunch. All attendees are requested to register.

"At UC Riverside, we have a novel focus – glial-neuronal interactions applied to a multiplicity of diseases," said Monica Carson, Ph.D., the director of the UCR Center for Glial-Neuronal Interactions (CGNI) and a professor of biomedical sciences in the School of Medicine, who is organizing the symposium. "We look at mechanisms common to all of these diseases, as well as how one disease differs from the rest. Our center is unique in that we examine glial-neuronal interactions at a level that few other centers worldwide do. We are very pleased to host the symposium for the tenth year in a row."

Carson, who is also the chair of Biomedical Sciences, said that glia play prominent and often causative roles in the development of many common neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, autism-spectrum disorders, epilepsy, Huntington's disease, stroke, multiple sclerosis, Parkinson's disease, and schizophrenia.

The keynote lecture will be given at 10 a.m. by Greg Lemke, Ph.D., whose lab has made major contributions to understanding the role that receptor tyrosine kinases (RTKs) play in mammalian development and physiology. Lemke is Françoise Gilot-Salk Professor at the Salk Institute for Biological Studies, where he is a member of the Molecular Neurobiology Laboratory and co-director of the Immunobiology and Microbial Pathogenesis Laboratory. He is also adjunct professor of neurosciences, and biomedical sciences, at UC San Diego. A major focus of his current research is the TAM family of RTKs — Tyro3, Axl, and Mer — and how this family functions in immune regulation, virus infection, and cancer.

See the complete schedule for the symposium.

The Glenn Hatton Lecture at 5 p.m. will be given by Tore Eid, M.D., Ph.D., an associate professor of laboratory medicine and the associate director of the Clinical Chemistry Laboratory at Yale-New Haven Hospital, Conn. Eid's research focuses on the discovery of novel diagnostics and therapeutics of epilepsy, one of the most common chronic neurological disorders in humans. The lecture honors the memory and vision of Glenn I. Hatton, a professor of cell biology and neuroscience at UCR who died in 2009.

###

Founded in 2007, CGNI, the first center in UCR's School of Medicine, facilitates innovative collaborations between neuro- and glial-centric researchers, as well as with researchers from outside the field of neuroscience. The goal is to understand how the central nervous system functions at the molecular level and to identify both risk factors for brain disease and therapeutic targets of intervention for neurodevelopmental, neurodegenerative and neuro-autoimmune disease.

The 10th annual "Glial-neuronal Interactions in Health and Disease" symposium is supported by UCR's School of Medicine, the Graduate Program in Biomedical Sciences, the Graduate Program in Neurosciences, the Glenn Hatton Memorial Fund, and several sponsors.

The University of California, Riverside (http://www.ucr.edu) is a doctoral research university, a living laboratory for groundbreaking exploration of issues critical to Inland Southern California, the state and communities around the world. Reflecting California's diverse culture, UCR's enrollment is now nearly 23,000 students. The campus opened a medical school in 2013 and has reached the heart of the Coachella Valley by way of the UCR Palm Desert Center. The campus has an annual statewide economic impact of more than $1 billion. A broadcast studio with fiber cable to the AT&T Hollywood hub is available for live or taped interviews. UCR also has ISDN for radio interviews. To learn more, call (951) UCR-NEWS.

Media Contact

Iqbal Pittalwala
[email protected]
951-827-6050
@UCRiverside

http://www.ucr.edu

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Oncofetal Plasticity Emerges in Early Colorectal Cancer

Oncofetal Plasticity Emerges in Early Colorectal Cancer

April 15, 2026
Scientists Develop Innovative Brain Model to Enhance Rapid and Adaptive Decision-Making

Scientists Develop Innovative Brain Model to Enhance Rapid and Adaptive Decision-Making

April 15, 2026

UT Health San Antonio Multispecialty and Research Hospital Enrolls First Participant in Groundbreaking Cancer Clinical Trial

April 15, 2026

Study Finds One in Five Assessed Soil Species Threatened with Extinction; Calls for Data on Thousands More

April 15, 2026
Please login to join discussion

POPULAR NEWS

  • Scientists Investigate Possible Connection Between COVID-19 and Increased Lung Cancer Risk

    61 shares
    Share 24 Tweet 15
  • Boosting Breast Cancer Risk Prediction with Genetics

    47 shares
    Share 19 Tweet 12
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    45 shares
    Share 18 Tweet 11
  • Revolutionary Theory Transforms Quantum Perspective on the Big Bang

    41 shares
    Share 16 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oncofetal Plasticity Emerges in Early Colorectal Cancer

Scientists Develop Innovative Brain Model to Enhance Rapid and Adaptive Decision-Making

UT Health San Antonio Multispecialty and Research Hospital Enrolls First Participant in Groundbreaking Cancer Clinical Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 79 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.